Quarterly report pursuant to Section 13 or 15(d)

EQUITY

v3.19.2
EQUITY
6 Months Ended
Jun. 30, 2019
Equity [Abstract]  
EQUITY EQUITY
Common Stock
During the second quarter of 2019, we issued 824,328 shares of common stock to holders of our 2.5% convertible senior notes due 2019 in settlement of $28.6 million of the outstanding principal amount of the notes.
Accumulated Other Comprehensive Loss
The following table presents changes in the components of AOCI, net of taxes, for the six months ended June 30, 2019:
 
Total (Foreign Currency Items)
 
(in thousands)
Balance at December 31, 2018
$
(145,231
)
Other comprehensive loss before reclassifications
(3,560
)
Net other comprehensive loss
(3,560
)
Balance at June 30, 2019
$
(148,791
)

Earnings Per Share
Basic net income (loss) per common share is computed by dividing the net income (loss) available to common stockholders by the weighted average number of common shares outstanding during the period. The calculation of diluted net income (loss) per common share includes the effects of the assumed exercise of any outstanding stock options, the assumed vesting of shares of restricted stock and the assumed conversion of our convertible senior notes where dilutive.
The following table sets forth the computation of weighted average common shares outstanding:
 
Three Months Ended 
 June 30,
 
Six Months Ended 
 June 30,
 
2019
 
2018
 
2019
 
2018
Weighted average common shares—basic
209,998,048

 
207,331,781

 
209,456,196

 
207,031,642

Effect of dilutive securities:
 
 
 
 
 
 
 
     Stock options and restricted stock
9,636,873

 
7,773,338

 
9,651,155

 
8,043,561

     Convertible senior notes
342,691

 

 

 

Weighted average common shares—diluted
219,977,612

 
215,105,119

 
219,107,351

 
215,075,203


The following table shows securities excluded from the calculation of diluted net income (loss) per common share because such securities are anti-dilutive:
 
Three Months Ended 
 June 30,
 
Six Months Ended 
 June 30,
 
2019
 
2018
 
2019
 
2018
Options to purchase shares of common stock
486,849

 
604,781

 
486,849

 
604,781

Restricted and deferred stock—unvested
1,326,480

 
2,668,381

 
1,365,825

 
2,627,154

Conversion shares related to the convertible senior notes
8,085,275

 
8,912,127

 
8,085,275

 
8,912,127

Number of anti-dilutive potentially issuable shares excluded from diluted common shares outstanding
9,898,604

 
12,185,289

 
9,937,949

 
12,144,062